Luminex Corporation To Present At Morgan Stanley Global Healthcare Conference
AUSTIN, Texas, Aug. 22, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Morgan Stanley Global Healthcare Conference to be held September 9 -11, 2013 in New York, NY.
The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 12:55 p.m. Eastern time (11:55 a.m. Central time) on Tuesday, September 10, 2013. The presentation will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the web at the address above, go to the Company section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the event to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the presentation will be archived for six months on the website using the 'replay' link.
About Luminex Corporation
Luminex is committed to applying its passion for innovation toward advancing healthcare and research worldwide. The Company is transforming global healthcare and life-science research through the development, manufacturing and marketing of proprietary instruments and assays utilizing xMAP open-architecture, multi-analyte platform and MultiCode® real-time polymerase chain reaction (PCR) and multiplex PCR-based technologies, that deliver cost-effective and rapid results to clinicians and researchers. Luminex's technology is commercially available worldwide and in use in leading clinical laboratories as well as major pharmaceutical, diagnostic, biotechnology and life-science companies. The Company is meeting the needs of customers in markets as diverse as clinical diagnostics, pharmaceutical drug discovery, biomedical research including genomic and proteomic research, personalized medicine, bio-defense research and food safety. For further information on Luminex Corporation and the latest advances in multiplexing using award winning technology, please visit http://www.luminexcorp.com/.
Luminex Investor Contact:
Harriss Currie, 512.219.8020
Sr. Vice President and CFO
Luminex Media Contact:
Mimi Torrington, 512.219.8020
Director of Marketing Communications
SOURCE Luminex Corporation
More by this Source
Luminex Corporation First Quarter Earnings Release Scheduled for April 28, 2014
Apr 07, 2014, 16:05 ET
Pioneering Human Protein Atlas Project Achieves a Major Milestone
Mar 17, 2014, 16:05 ET
Luminex Corporation Reports Fourth Quarter And Full Year 2013 Results
Feb 03, 2014, 16:05 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.